Novo Nordisk’s CEO Steps Down Amid Market Challenges
Novo Nordisk, maker of weight loss drug Wegovy, announced Friday that its CEO Lars Fruergaard Jorgensen is stepping down after “recent market challenges” and a steep decline in the company’s share price. The decision comes as the company faces competition from cheaper replica drugs and a study showing that another weight loss medication, Zepbound, was … Read more